JobDrop

Alnylam Pharmaceuticals jobs

Browse current Alnylam Pharmaceuticals openings that JobDrop found directly from the company's careers source.

About Alnylam

Alnylam Pharmaceuticals · Leadership Diversity, Equity, Country not listed · First seen 2026-06-03

## The Leader in RNAi Therapeutics Medicines based on RNAi work by “silencing” or disabling the production (“expression”) of the genes that cause specific diseases. Since our medicines work at a genetic level, we believe that we can develop small interfering RNAs that can silence virtually any gene in the genome, meani

Alnylamrnaitherapeuticsmedicinesleaderbasedsilencingdisabling

Leadership

Alnylam Pharmaceuticals · Leadership Diversity, Equity, Country not listed · First seen 2026-06-03
Leadership

Patient Access Philosophy

Alnylam Pharmaceuticals · Leadership Diversity, Equity, Country not listed · First seen 2026-06-03
PatientAccessPhilosophy

Corporate Responsibility

Alnylam Pharmaceuticals · Leadership Diversity, Equity, Country not listed · First seen 2026-06-03
CorporateResponsibility

Alnylam Challengers

Alnylam Pharmaceuticals · Leadership Diversity, Equity, Country not listed · First seen 2026-06-03

Frontline care navigators and community health workers help patients navigate health systems and access essential services, including preventive screenings, food, housing, and transportation.

AlnylamChallengershealthfrontlinecarenavigatorscommunityworkers

Transparency

Alnylam Pharmaceuticals · Leadership Diversity, Equity, Country not listed · First seen 2026-06-03
Transparency

Grants & Giving

Alnylam Pharmaceuticals · Leadership Diversity, Equity, Country not listed · First seen 2026-06-03
GrantsGiving

The Science of RNAi

Alnylam Pharmaceuticals · Leadership Diversity, Equity, Country not listed · First seen 2026-06-03
ScienceRNAi

Delivery Platforms

Alnylam Pharmaceuticals · Leadership Diversity, Equity, Country not listed · First seen 2026-06-03
DeliveryPlatforms

Making Our Medicines

Alnylam Pharmaceuticals · Leadership Diversity, Equity, Country not listed · First seen 2026-06-03

## How Our RNAi Therapeutics are Made siRNA (small interfering RNA) manufacturing provides the chemical building blocks that form the drug substance of our RNAi therapeutics and other genetically-based therapeutic technologies. This type of manufacturing is a complex, time-consuming process that requires specialized fa

MakingMedicinesrnaitherapeuticsmanufacturingmadesirnasmall

Therapeutic Areas

Alnylam Pharmaceuticals · Leadership Diversity, Equity, Country not listed · First seen 2026-06-03
TherapeuticAreas

Clinical Trials

Alnylam Pharmaceuticals · Leadership Diversity, Equity, Country not listed · First seen 2026-06-03
ClinicalTrials

Scientific Advisory Board

Alnylam Pharmaceuticals · Leadership Diversity, Equity, Country not listed · First seen 2026-06-03
ScientificAdvisoryBoard

Intellectual Property

Alnylam Pharmaceuticals · Leadership Diversity, Equity, Country not listed · First seen 2026-06-03
IntellectualProperty

Product Listing

Alnylam Pharmaceuticals · Leadership Diversity, Equity, Country not listed · First seen 2026-06-03
ProductListing

Media Kit

Alnylam Pharmaceuticals · Leadership Diversity, Equity, Country not listed · First seen 2026-06-03
MediaKit

For Medical Professionals

Alnylam Pharmaceuticals · Leadership Diversity, Equity, Country not listed · First seen 2026-06-03
ForMedicalProfessionals

Genetic Testing & Counseling

Alnylam Pharmaceuticals · Leadership Diversity, Equity, Country not listed · First seen 2026-06-03
GeneticTestingCounseling

Early Access Program

Alnylam Pharmaceuticals · Leadership Diversity, Equity, Country not listed · First seen 2026-06-03
EarlyAccessProgram

Medical Publication Support

Alnylam Pharmaceuticals · Leadership Diversity, Equity, Country not listed · First seen 2026-06-03
MedicalPublicationSupport

For Patients

Alnylam Pharmaceuticals · Leadership Diversity, Equity, Country not listed · First seen 2026-06-03
ForPatients

Amyloidosis

Alnylam Pharmaceuticals · Leadership Diversity, Equity, Country not listed · First seen 2026-06-03
Amyloidosis

Acute Hepatic Porphyria

Alnylam Pharmaceuticals · Leadership Diversity, Equity, Country not listed · First seen 2026-06-03
AcuteHepaticPorphyria

Primary Hyperoxaluria

Alnylam Pharmaceuticals · Leadership Diversity, Equity, Country not listed · First seen 2026-06-03

## PH1 Manifestations Can Vary By Stage of Life Patients can be diagnosed with PH1 at any age, but most individuals experience their first symptoms in early childhood. Below are some examples of possible symptoms, but are not limited to such.

PrimaryHyperoxaluriasymptomsmanifestationsvarystagelifepatients

Patient Services

Alnylam Pharmaceuticals · Leadership Diversity, Equity, Country not listed · First seen 2026-06-03
PatientServices

Genetic Testing and Counseling

Alnylam Pharmaceuticals · Leadership Diversity, Equity, Country not listed · First seen 2026-06-03
GeneticTestingCounseling

Patient Advocacy

Alnylam Pharmaceuticals · Leadership Diversity, Equity, Country not listed · First seen 2026-06-03

## Additional Alnylam Resources We are committed to supporting patients and their families throughout their journey with a wide range of programs and services—from diagnosis to access to treatment and care.

PatientAdvocacyadditionalalnylamresourcescommittedsupportingpatients

About Careers

Alnylam Pharmaceuticals · Jobs Diversity, Equity, Country not listed · First seen 2026-06-03
Careers

Working at Alnylam

Alnylam Pharmaceuticals · Jobs Diversity, Equity, Country not listed · First seen 2026-06-03

## Alnylam Is Employee-Driven “Change the world” kind of people tend to have a lot of good ideas, and a lot of passion for those good ideas. We love that and empower our employees to bring those ideas to life, within both Alnylam and our communities, through Employee Resource Networks (ERNs) or other types of employee-

Alnylamgoodideasthoseemployee-drivenchangekindtend

Deutsch

Alnylam Pharmaceuticals · Country not listed · First seen 2026-06-03
Deutsch

Nederlands

Alnylam Pharmaceuticals · Country not listed · First seen 2026-06-03
Nederlands

Français

Alnylam Pharmaceuticals · Country not listed · First seen 2026-06-03
Franais

Français

Alnylam Pharmaceuticals · Country not listed · First seen 2026-06-03
Franais

Deutsch

Alnylam Pharmaceuticals · Country not listed · First seen 2026-06-03
Deutsch

Português

Alnylam Pharmaceuticals · Country not listed · First seen 2026-06-03

## Transformando o Tratamento de Doenças Nossas terapias inovadoras de RNAi silenciam genes que causam ou contribuem para doenças

Portugudoentransformandotratamentonossasterapiasinovadorasrnai

Nederlands

Alnylam Pharmaceuticals · Country not listed · First seen 2026-06-03
Nederlands

Português

Alnylam Pharmaceuticals · Country not listed · First seen 2026-06-03
Portugu

Español

Alnylam Pharmaceuticals · Country not listed · First seen 2026-06-03
Espa

Dansk

Alnylam Pharmaceuticals · Country not listed · First seen 2026-06-03

## Silence Disease. Amplify Life. When RNAi silences the genes that cause disease, the best parts of life can be amplified.

Dansksilencediseaseamplifylifernaisilencesgenes

Svenska

Alnylam Pharmaceuticals · Country not listed · First seen 2026-06-03

## Silence Disease. Amplify Life. When RNAi silences the genes that cause disease, the best parts of life can be amplified.

Svenskasilencediseaseamplifylifernaisilencesgenes

Français

Alnylam Pharmaceuticals · Country not listed · First seen 2026-06-03
Franais

Deutsch

Alnylam Pharmaceuticals · Country not listed · First seen 2026-06-03
Deutsch

Italiano

Alnylam Pharmaceuticals · Country not listed · First seen 2026-06-03
Italiano

繁體中文

Alnylam Pharmaceuticals · Country not listed · First seen 2026-06-03

Sign Up

Alnylam Pharmaceuticals · Country not listed · First seen 2026-06-03
Sign

Site Map

Alnylam Pharmaceuticals · Country not listed · First seen 2026-06-03
SiteMap